Clarity Pharmaceuticals Ltd. (AU:CU6) has released an update.
Clarity Pharmaceuticals Ltd. has announced the application for quotation of 191,898 new ordinary shares under the ASX security code CU6. The application follows the exercise of options or conversion of other securities, as detailed in their June 20, 2024, announcement. This move signals a potential expansion in Clarity Pharmaceuticals’ market presence and could be of interest to investors.
For further insights into AU:CU6 stock, check out TipRanks’ Stock Analysis page.
